Form 4: National Health Investors CEO Acquires Shares and Stock Options
SEC Form 4
D. Eric Mendelsohn, CEO and President of National Health Investors, reports acquisition of shares and stock options.
Summary
- D. Eric Mendelsohn, CEO and President of National Health Investors, filed a Form 4 detailing changes in beneficial ownership.
- On March 3, 2025, Mendelsohn acquired 8,000 shares of common stock.
- Mendelsohn also acquired stock options to purchase 25,000 shares of common stock at an exercise price of $73.34, exercisable in tranches from March 3, 2025, to March 3, 2027, and expiring on March 3, 2030.
- Following these transactions, Mendelsohn beneficially owns 96,527 shares of common stock.
- Mendelsohn also holds various other stock options granted in previous years.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive as the CEO's increased stake in the company suggests confidence, but it's a routine filing and doesn't provide groundbreaking information.
Positives
- The CEO's acquisition of shares and stock options could be interpreted as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice and provide transparency regarding insider transactions, allowing investors to track management's alignment with shareholder interests.
Comparison to Industry Standards
- Comparing the CEO's stock ownership to peers in the healthcare REIT sector can provide insights into relative alignment with shareholder value.
- Analyzing the vesting schedules and exercise prices of stock options against industry norms can reveal the competitiveness of the company's executive compensation packages.
- Companies like Welltower (WELL) and Ventas (VTR) are key competitors in the healthcare REIT space, and their executive compensation structures can serve as benchmarks.
Stakeholder Impact
- Shareholders may view the CEO's increased ownership as a positive sign.
- Employees may see this as a sign of stability and confidence in the company's leadership.
- Creditors may perceive reduced risk due to the CEO's increased alignment with the company's success.
Key Dates
| Date | Description |
|---|---|
| 02/25/2021 | Grant date of stock options with a strike price of $69.2 |
| 02/25/2022 | Stock options granted on 02/25/2021 become exercisable |
| 02/25/2023 | Stock options granted on 02/25/2021 become exercisable |
| 02/24/2025 | Stock options granted in 2023 become exercisable |
| 02/23/2025 | Stock options granted in 2024 become exercisable |
| 03/03/2025 | Date of transaction: Acquisition of common stock and stock options. |
| 03/03/2026 | First vesting date for restricted stock granted on 03/03/2025. |
| 02/23/2026 | Stock options granted in 2024 become exercisable |
| 02/25/2026 | Expiration date of stock options granted on 02/25/2021 |
| 03/03/2027 | Stock options granted on 03/03/2025 become exercisable |
| 02/24/2028 | Expiration date of stock options granted in 2023 |
| 02/23/2029 | Expiration date of stock options granted in 2024 |
| 03/03/2030 | Expiration date of stock options granted on 03/03/2025 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.